Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Breast Cancer Research and Treatment|April 19, 2017
Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expressionMonica E Reyes, Takeo Fujii, Daniel Branstetter, et al.Journal of Cancer|March 14, 2015
Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast CancerTakahiro Kogawa, Tamer M Fouad, Caimiao Wei, et al.Cancer Medicine|December 19, 2019
Phase II study of Radium-223 dichloride combined with hormonal therapy for hormone receptor-positive, bone-dominant metastatic breast cancerNaoto T Ueno, Rie K Tahara, Takeo Fujii, et al.Clinical Breast Cancer|August 6, 2018
Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution ExperienceRashmi K Murthy, Akshara S Raghavendra, Kenneth R Hess, et al.Investigational New Drugs|October 28, 2017
Radiomics to predict immunotherapy-induced pneumonitis: proof of conceptRivka R Colen, Takeo Fujii, Mehmet Asim Bilen, et al.Plos One|July 4, 2008
Periodontal tissue regeneration using fibroblast growth factor-2: randomized controlled phase II clinical trialMasahiro Kitamura, Keisuke Nakashima, Yusuke Kowashi, et al.Breast Cancer Research and Treatment|June 16, 2021
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scoresTakeo Fujii, Hiroko Masuda, Yee Chung Cheng, et al.Plos One|September 29, 2017
Androgen receptor expression on circulating tumor cells in metastatic breast cancerTakeo Fujii, James M Reuben, Lei Huo, et al.Investigational New Drugs|November 22, 2017
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experienceTakeo Fujii, Rivka R Colen, Mehmet Asim Bilen, et al.Research Square|June 5, 2026
SYNTHESIS-Breast: A prospective early-phase trial of a genetic-interaction- focused computational algorithm in advanced metastatic breast cancerAanika B Warner, Britanny B Solarz, Miroslava Belyov, et al.Pageof 7